Janux Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
AVALON VENTURES XI, L.P. 10 percent owner
 Common Stock 677,279 $54.75 $37,081,025
Sale
LICHTER JAY director, 10 percent owner:
Common Stock 677,279 $54.75 $37,081,025
Sale
LICHTER JAY director, 10 percent owner:
Common Stock 131,196 $54.75 $7,182,981
Sale
REARDON TIGHE officer: Acting Chief Financial..
 Common Stock 691,525 $54.75 $37,860,994
Sale
LICHTER JAY director, 10 percent owner:
Common Stock 691,525 $54.75 $37,860,994
Sale
AVALON VENTURES XI, L.P. 10 percent owner
 Common Stock 131,196 $54.75 $7,182,981
Purchase
RA CAPITAL MANAGEMENT, L.P. director, 10 percent owner:
Pre-Funded Warrants (Right to Buy) 1,397,849 $0 $1,398
Purchase
AVALON VENTURES XI, L.P. 10 percent owner
 Common Stock 849,854 $5.87 $4,988,643
Purchase
REARDON TIGHE 10 percent owner, officer: Acti..
 Common Stock 849,854 $5.87 $4,988,643
Purchase
LICHTER JAY director, 10 percent owner:
Common Stock 849,854 $5.87 $4,988,643
Purchase
RA CAPITAL MANAGEMENT, L.P. director, 10 percent owner:
Common Stock 495,008 $12.46 $6,167,800
Purchase
RA CAPITAL MANAGEMENT, L.P. director, 10 percent owner:
Pre-Funded Warrants (Right to Buy) 503,226 $0 $503
Sale
ORBIMED ADVISORS LLC director
 Common Stock 3,700 $20.3 $75,110
Sale
ORBIMED ADVISORS LLC director
 Common Stock 36,700 $20.3 $745,010
Sale
THOMPSON PETER A. director
 Common Stock 3,700 $20.3 $75,110
Sale
THOMPSON PETER A. director
 Common Stock 36,700 $20.3 $745,010
Sale
ORBIMED ADVISORS LLC director
 Common Stock 11,100 $19 $210,900
Sale
ORBIMED ADVISORS LLC director
 Common Stock 108,300 $19 $2,057,700
Sale
THOMPSON PETER A. director
 Common Stock 11,100 $19 $210,900
Sale
THOMPSON PETER A. director
 Common Stock 108,300 $19 $2,057,700
Sale
THOMPSON PETER A. director
 Common Stock 36,500 $19.07 $696,055
Sale
THOMPSON PETER A. director
 Common Stock 356,800 $19.07 $6,804,176
Sale
ORBIMED ADVISORS LLC director
 Common Stock 36,500 $19.07 $696,055
Sale
ORBIMED ADVISORS LLC director
 Common Stock 356,800 $19.07 $6,804,176
Purchase
AVALON VENTURES XI, L.P.
Common Stock 629,411 $17 $10,699,987
Purchase
ORBIMED ADVISORS LLC
Common Stock 705,853 $17 $11,999,501
Purchase
BREGUA CORP
Common Stock 58,823 $17 $999,991
Purchase
RA CAPITAL MANAGEMENT, L.P.
Common Stock 2,941,176 $17 $49,999,992
Purchase
LICHTER JAY
Common Stock 629,411 $17 $10,699,987
Purchase
REARDON TIGHE
Common Stock 629,411 $17 $10,699,987
Purchase
THOMPSON PETER A.
Common Stock 705,853 $17 $11,999,501

Showing 100 to 131 of 131 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: